Revolution Medicines (RVMD) Goodwill & Intangibles (2019 - 2026)

Revolution Medicines' Goodwill & Intangibles history runs 8 years deep, the most recent figure standing at $70.4 million for Q1 2026.

• In Q1 2026, Goodwill & Intangibles fell 9.6% year-over-year to $70.4 million; the TTM figure through Mar 2026 stood at $70.4 million (down 9.6% YoY), while the FY2025 annual figure was $70.4 million, down 1.22% from the prior year.
• Goodwill & Intangibles for Q1 2026 stood at $70.4 million, roughly flat from $70.4 million in the prior quarter.
• The five-year high for Goodwill & Intangibles was $111.7 million in Q2 2024, with the low at $70.4 million in Q1 2023.
• The 5-year median for Goodwill & Intangibles is $72.6 million (2023), against an average of $75.3 million.
• The sharpest annual moves came in 2024 and 2025: Goodwill & Intangibles jumped 53.3% in 2024, then slumped 36.68% in 2025.
• Revolution Medicines' Goodwill & Intangibles stood at $73.4 million in 2022, then dropped by 1.45% to $72.3 million in 2023, then retreated by 1.48% to $71.3 million in 2024, then decreased by 1.22% to $70.4 million in 2025, then changed by 0.0% to $70.4 million in 2026.
• Business Quant data shows RVMD's Goodwill & Intangibles at $70.4 million in Q1 2026, $70.4 million in Q4 2025, and $77.9 million in Q3 2025.